LIVN
LivaNova PLCNASDAQHealthcare$63.79-1.30%ClosedMarket Cap: $3.49B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.88
P/S
2.50
EV/EBITDA
-27.46
DCF Value
$-12.78
FCF Yield
5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
68.0%
Operating Margin
14.4%
Net Margin
-17.5%
ROE
-21.5%
ROA
-9.3%
ROIC
10.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $360.9M | 66.4% | $42.6M | $30.9M | $0.57 | — |
| FY 2025 | $1.39B | 67.7% | $199.4M | $-242.5M | $-4.45 | — |
| Q3 2025 | $357.8M | 68.4% | $54.0M | $26.8M | $0.49 | — |
| Q2 2025 | $352.5M | 67.8% | $54.2M | $27.2M | $0.50 | — |
| Q1 2025 | $316.9M | 69.7% | $48.6M | $-327.3M | $-6.01 | — |
| Q4 2024 | $321.8M | 68.2% | $37.0M | $55.9M | $1.02 | — |
| FY 2024 | $1.25B | 69.5% | $129.1M | $63.2M | $1.16 | — |
| Q3 2024 | $318.1M | 70.8% | $35.6M | $33.0M | $0.60 | — |
| Q2 2024 | $318.6M | 67.4% | $40.2M | $16.3M | $0.30 | — |
| Q1 2024 | $294.9M | 70.3% | $16.2M | $-41.9M | $-0.78 | — |
| Q4 2023 | $310.1M | 61.3% | $-88.0M | $16.3M | $0.30 | — |
| FY 2023 | $1.15B | 66.9% | $-68.5M | $17.5M | $0.32 | — |